0001757610-23-000002.txt : 20230620 0001757610-23-000002.hdr.sgml : 20230620 20230620112206 ACCESSION NUMBER: 0001757610-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 EFFECTIVENESS DATE: 20230620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zyus Life Sciences Inc. CENTRAL INDEX KEY: 0001757610 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-484583 FILM NUMBER: 231023988 BUSINESS ADDRESS: STREET 1: 407 DOWNEY RD STREET 2: SUITE 204 CITY: SASKATOON STATE: A9 ZIP: SLN4L8 BUSINESS PHONE: 306-651-7711 MAIL ADDRESS: STREET 1: 407 DOWNEY RD STREET 2: SUITE 204 CITY: SASKATOON STATE: A9 ZIP: SLN4L8 FORMER COMPANY: FORMER CONFORMED NAME: CB3 Life Sciences Ltd. DATE OF NAME CHANGE: 20181030 D 1 primary_doc.xml X0708 D LIVE 0001757610 Zyus Life Sciences Inc. 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 306-651-7711 SASKATCHEWAN, CANADA CB3 Life Sciences Ltd. Corporation true 2018 BRENT ZETTL 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Executive Officer Chief Executive Officer John Hyshka 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Executive Officer Chief Financial Officer Keith Carpenter 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Executive Officer Chief Strategy Officer John Knowles 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Director Richard Hoyt 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Director Dr. Lionel Marks de Chabris 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Executive Officer Chief Medical Officer Garnette Weber 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Director Other Health Care Decline to Disclose 06b false 2023-06-05 false true true The offering was conducted in conjunction with a reverse take-over transaction between the Issuer and Phoenix Canada Oil Company Limited. 0 Stifel, Nicolaus & Company, Incorporated 793 None None 501 NORTH BROADWAY ST. LOUIS MO MISSOURI 63102 CT CONNECTICUT MO MISSOURI MA MASSACHUSETTS FL FLORIDA NY NEW YORK false Roth Capital Partners, LLC 15407 None None 888 SAN CLEMENTE SUITE 400 NEWPORT BEACH CA CALIFORNIA 92660 CT CONNECTICUT MO MISSOURI MA MASSACHUSETTS FL FLORIDA NY NEW YORK false Haywood Securities (USA) Inc. 42072 None None 200 BURRARD ST SUITE 700 VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 3L6 CT CONNECTICUT MO MISSOURI MA MASSACHUSETTS FL FLORIDA NY NEW YORK false 1147152 1147152 0 The total amount reflected in this section is based on a conversion rate of 1 USD = 1.343 CAD as of June 5 2023, and is reflective of the total offers and sales made in the U.S. only. false 6 47366 0 0 false Zyus Life Sciences Inc. /s/ Brent Zettl Brent Zettl CEO 2023-06-20